SABSW

Conviction 0HealthcareScan · Mon, Aug 10, 2026

SABSW$0.0112-52.74%

ResistanceSupportVol 14

Vol MA14 98.12K

May 8May 27Jun 15Jul 2Jul 22Aug 7

SAB Biotherapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.sab.bio ↗

Price0.0112

Change-52.74%

Gap+21.52%

Rel volume0.06×

Avg volume94.6K

Avg $ vol1.66K

SMA 200.0151

SMA 500.0115

SMA 2000.0189

Price vs 50-2.25%

Price vs 200-40.72%

MA stackbearish

50/200 cross—

Supertrendup · 0.0030

RSI (14)48

MACD hist0.00

MACD crossbull · 5d

Stoch %K / %D37 / 60

ADX (14)27

+DI / −DI36 / 21

RSI divergence—

MACD divergenceBearish

ATR %+79.08%

ADR %46.37%

52w high0.0477

52w low0.0000

From 52w high-76.52%

Above 52w low—

New 52w highNo

SqueezeOn · 16d

Bollinger width115.71%

%B0.28

Donchian pos36.69%

Donchian high0.0288

Donchian low0.0010

AVWAP (52w high)0.0239

vs AVWAP high-53.10%

AVWAP (52w low)0.0243

vs AVWAP low-53.91%

OBV trendUp

Chaikin MF (20)0.27

Today vs 20d0.06×

Avg vol (14d)98.12K

Avg vol (20d)94.6K

Avg $ vol (20d)1.66K

Market cap1.02M

RS 3m (vs SPY)-69.22%

RS 6m (vs SPY)-88.07%

RS line new highNo

Trend template0/8

Technical rank13.2

1 week-44.00%

1 month-27.27%

3 months-63.52%

6 months-73.95%

1 year-61.38%

YTD-63.87%

P/E0.08

P/B0.00

P/S—

P/FCF-0.02

EPS-0.7900

Div yield—

ROE6.18%

ROA5.57%

Debt/Eq—

Current9.22

EV/EBITDA0.16

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth138.92%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-7.25M

Revenue263.14K

Net income-22.49M

Gross profit—

Free cash flow-45.71M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out—

Employees86

ListedFri, Oct 22, 2021

Free float90.99M

Float %100.0%

Short interest9.52K

Days to cover0.0d

Short volume94.8%

Squeeze score20 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank13.2 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.0415

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SABSW

All disclosures →

No recent disclosed trades by Congress in SABSW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SABSW

No recent insider (Form 4) filings in SABSW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in SABSW

EDGAR →

No recent SEC filings on file for SABSW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.